• Already, a coalition was forged between Adams and academics at the Dana-Farber Cancer Institute and the National Cancer Institute.

    FORBES: Magazine Article

  • Researchers at the Dana-Farber Cancer Institute in Boston took Celgene's improved version, Revlimid, and rushed it into myeloma trials.

    FORBES: Health

  • "This has profound implications, " says researcher Thomas Look of Boston's Dana-Farber Cancer Institute.

    FORBES: Cancer Killer

  • There seems to be no end of customers-including the Kennedy Space Center, Cargill, Dana-Farber Cancer Institute in Boston, Unilever and military bases.

    FORBES: Germ Warfare

  • The current trial by George Demetri, a GIST expert at the Dana-Farber Cancer Institute, tested SU-11248 in patients who had failed Gleevec.

    FORBES: Pfizer Cancer Pill Proves Effective

  • Winer, director of the Breast Oncology Center at the Dana-Farber Cancer Institute.

    FORBES: Questions Swirl Around Avastin

  • "I keep telling them that they need to think more like a biotech, " says George Demetri , an oncologist at the Dana-Farber Cancer Institute.

    FORBES: Pfizer Takes Cancer By Storm

  • Demetri of the Dana-Farber Cancer Institute, who codesigned trials of AP23573 after big successes with other fast-tracked pills, such as Gleevec and Pfizer's Sutent.

    FORBES: Mission Improbable

  • There seems to be no end of customers they include the Kennedy Space Center, Cargill, the Dana-Farber Cancer Institute in Boston, Massachusetts, Unilever and military bases.

    FORBES: Germ warfare

  • Gary Gilliland, a hematologist at the Dana-Farber Cancer Institute, used a Web discussion board to recruit hundreds of patients willing to give him genetic samples.

    FORBES: Magazine Article

  • Dr. Eric Weiner of Dana-Farber Cancer Institute in Boston says it's really unusual for a drug to be so effective such a long time after diagnosis.

    NPR: Study: Drug Can Curb Breast Cancer Recurrence

  • Under the microscope "it looks like a small bomb went off in the nucleus, " says George Demetri, an oncologist at the Dana-Farber Cancer Institute in Boston.

    FORBES

  • "I don't know anyone who offers women the option of doing nothing, " says Eric Winer, director of the breast cancer program at Dana-Farber Cancer Institute in Boston.

    WSJ: Can Breast Cancer Be Overtreated?

  • But the debilitating effects on a patient's sexuality are often ignored, said Sharon Bober, director of the sexual health program at the Dana-Farber Cancer Institute in Boston.

    CNN: Let's talk about sex ... and cancer

  • "Definitive studies to show it is better than Taxol have yet to be done, " says Eric Winer, a top breast cancer researcher at the Dana- Farber Cancer Institute.

    FORBES: Patrick Soon-Shiong and one of cancer's biggest riddles.

  • " Says Robert Mayer , director of the center for gastrointestinal oncology at the Dana-Farber Cancer Institute: "I think it's hard to be anything but enthusiastic about the results.

    FORBES: Magazine Article

  • "That's very impressive, " says Paul Richardson, a myeloma specialist at the Dana-Farber Cancer Institute who has worked on other Celgene-sponsored trials but did not participate in this Thalomid study.

    FORBES: Thalomid Fuels Celgene's Rise

  • "That is absolutely the case, " agrees Dr. Ann Partridge, clinical director of the Breast Oncology Center at the Dana-Farber Cancer Institute, who also does research on improving health care communication.

    CNN: Cancer survivor's own fat gives her new breasts

  • "The two different types have fairly dramatically different clinical behaviors, " said Matthew Kulke, director of the carcinoid and pancreatic neuroendocrine tumor program at the Harvard-affiliated Dana-Farber Cancer Institute in Boston.

    WSJ: Apple Co-Founder Steve Jobs's Rare Disease Ran Predictable Course

  • Slovenia, and a radiation oncologist at Dana-Farber Cancer Institute.

    FORBES: When 450,000 People Can't be Wrong

  • He splits his time with the Dana-Farber Cancer Institute.

    FORBES: A Cancer Patient's Quest Hits DNA Pay Dirt

  • "You get a broad range from hoaxes, charlatans and self-centered megalomaniacs to extraordinary altruism and everything in the middle, " says George Demetri, an oncologist at the Dana-Farber Cancer Institute in Boston, Mass.

    FORBES: Magazine Article

  • In a study conducted with the Dana-Farber Cancer Institute and published in Nature Medicine, found that more than half of patients with lung and colon cancer might benefit from the test.

    FORBES: Bill Gates Invests In Cancer DNA Sequencing Firm

  • In fact, it is the other way round at least according to a study published in the Journal of the American Medical Association by Andrea Phelps and her colleagues at the Dana-Farber Cancer Institute in Boston.

    ECONOMIST: Religion, medicine and death

  • In some cases, drug companies may want to avoid interfering with key proteins to avoid too many unintended side effects, says Marc Vidal, director of the Center for Cancer Systems Biology at Dana-Farber Cancer Institute in Boston.

    WSJ: Genes May Link Disparate Diseases

  • "These are among the most significant findings in drugs for metastatic cancer in the past five years, " said Eric Winer, director of the breast oncology center at Dana-Farber Cancer Institute in Boston, who wasn't directly involved in the trials.

    WSJ: Breast-Cancer Drugs Raise Hopes

  • Anderson of the Dana-Farber Cancer Institute.

    FORBES: Celgene Aims For Fast FDA Approval

  • "If we can individualize therapy, the nirvana is that ten years from now a person comes to the clinic, and we can genomically analyze their disease, " says Paul Richardson of the Dana-Farber Cancer Institute at Harvard University, who led the trials.

    FORBES: Genomics Revolution Actually Happens

  • John Quackenbush, previously a member of TIGR's faculty and a professor at the Dana-Farber Cancer Institute, says that the "vanity genome, " which he saw as a drain on resources, was one of the things he protested when the TIGR faculty went to the institute's board to try and preserve Fraser's job.

    FORBES: All Mapped Out

  • This study, which was led by Paul Richardson at the Dana-Farber Institute, tested only the sickest patients suffering from a relatively rare cancer called multiple myeloma.

    FORBES: Millennium's Future

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定